Clinical Trial News, Clinical Trials, Clinical Trials
Friday, August 21st, 2015
Diabetes Care 26 June 2015 OBJECTIVE The role of telemedical monitoring in diabetic foot ulcer care is still uncertain. Our aim was to compare telemedical and standard outpatient monitoring in the care of patients with diabetic foot ulcers in a randomized controlled trial.… CONCLUSIONS The findings of no significant difference regarding amputation and healing between […]
Clinical Trial News, Clinical Trials, Clinical Trials
Friday, August 21st, 2015
Diabetes Care, 17 June 2015 OBJECTIVE To evaluate the impact of exercise training (ET) on metabolic parameters among participants with type 2 diabetes mellitus (T2DM) who do not improve their cardiorespiratory fitness (CRF) with training.… CONCLUSIONS ET is associated with significant improvements in metabolic parameters irrespective of improvement in cardiorespiratory fitness. Read more.
Clinical Trial News, Clinical Trials, Clinical Trials
Friday, August 21st, 2015
Am J Clin Nutr, 25 March 2015 Background: Epidemiologic studies have linked high consumption of red and processed meat with risk of developing type 2 diabetes, whereas high dairy consumption has been associated with decreased risk, but interventions have been limited. Objective: We compared the effects on insulin sensitivity of consuming a diet high in […]
Clinical Trial News, Clinical Trials, Clinical Trials
Friday, August 21st, 2015
Diabetes Care, March 2015 OBJECTIVE To compare pharmacokinetics (PK) and pharmacodynamics (PD) of insulin glargine in type 2 diabetes mellitus (T2DM) after evening versus morning administration.… CONCLUSIONS The PD of insulin glargine differs depending on time of administration. With morning administration insulin activity is greater in the first 0–12 h, while with evening administration the […]
Clinical Trial News, Clinical Trials, Clinical Trials
Friday, August 21st, 2015
Diabetes Care, 9 September 2014 OBJECTIVE To assess the efficacy/safety of canagliflozin, a sodium–glucose cotransporter 2 inhibitor, compared with glimepiride over 104 weeks in patients with type 2 diabetes inadequately controlled with metformin.… CONCLUSIONS Canagliflozin provided durable glycemic improvements compared with glimepiride and was generally well tolerated in patients with type 2 diabetes receiving background […]
